Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonance
Henry JA. et al, (2024), Heart
Dye-based chromoendoscopy detects more neoplasia than white light endoscopy in patients with primary sclerosing cholangitis and IBD.
Motta RV. et al, (2024), Endoscopy international open, 12, E1285 - E1294
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH. et al, (2024), The New England journal of medicine
Prospective cohort for early detection of liver cancer (Pearl): a study protocol
Khanna K. et al, (2024), BMJ Open, 14, e085541 - e085541
Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Overbeek KA. et al, (2024), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22, 994 - 1004.e10
Challenges and pitfalls in the diagnosis of IgG4-related disease.
Bateman AC. and Culver EL., (2024), Seminars in diagnostic pathology, 41, 45 - 53
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
Jones DE. et al, (2024), Hepatology (Baltimore, Md.)
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis.
Shah A. et al, (2024), Hepatology communications, 8
IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease.
Motta RV. and Culver EL., (2024), Frontiers in immunology, 15
Investigating the cardiac manifestations of IgG4-related disease using cardiac magnetic resonance imaging
Henry JA. et al, (2023), European Heart Journal, 44
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.
Perugino C. et al, (2023), Rheumatology and therapy
Autoimmune pancreatitis in patients with inflammatory bowel disease - a real-world multicentre collaborative ECCO CONFER study.
Eder P. et al, (2023), Journal of Crohn's & colitis
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis.
Abbas N. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 21, 1561 - 1570.e13
Disparities in care and outcomes for primary liver cancer in England during 2008–2018: a cohort study of 8.52 million primary care population using the QResearch database
Liao W. et al, (2023), eClinicalMedicine, 59, 101969 - 101969
Development of an algorithm for IgG4-related disease management.
Orozco-Gálvez O. et al, (2023), Autoimmunity reviews, 22
Secondary sclerosing cholangitis and IgG4-sclerosing cholangitis - A review of cholangiographic and ultrasound imaging.
Möller K. et al, (2023), Endoscopic ultrasound, 12, 181 - 199
Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study.
Schregel I. et al, (2023), Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Patient Priorities in Autoimmune Hepatitis: The Need for Better Treatments, More Education and Challenging Stigma.
Lloyd C. et al, (2023), Digestive diseases and sciences, 68, 87 - 97